Antoine Yver

Antoine Yver

Direttore/Membro del Consiglio presso SANOFI
68 anni
Health Technology
Distribution Services
Consumer Services

Profilo

Antoine Yver currently works at Sanofi, as Independent Director from 2022, Spotlight Therapeutics, Inc., as Director from 2022, and Stipple Bio Inc., as Director.
Dr. Yver also formerly worked at Centessa Pharmaceuticals Plc, as Executive Vice President & Chairman-Development from 2022 to 2024, Aventis SA, as Senior Director-Clinical Research from 1990 to 2005, Schering-Plough SAS, as Executive Director-Oncology from 2006 to 2009, Johnson & Johnson Medical SAS, as Senior Director-Oncology from 2005 to 2006, AstraZeneca PLC, as Head-Global Medicines Development from 2015 to 2016, and Daiichi Sankyo Co., Ltd., as EVP, Global Head-Oncology Research and Development from 2016 to 2021.
Dr. Yver received his undergraduate degree and doctorate degree from Université Paris-Saclay.

Posizioni attive di Antoine Yver

SocietàPosizioneInizio
SANOFI Direttore/Membro del Consiglio 03/05/2022
Direttore/Membro del Consiglio 04/07/2022
Direttore/Membro del Consiglio -

Precedenti posizioni note di Antoine Yver

SocietàPosizioneFine
CENTESSA PHARMACEUTICALS PLC Direttore Tecnico/Scientifico/R&S 07/03/2022
DAIICHI SANKYO COMPANY, LIMITED Corporate Officer/Principal 01/04/2021
ASTRAZENECA PLC Corporate Officer/Principal 01/01/2016
Corporate Officer/Principal 01/01/2009
Corporate Officer/Principal 01/01/2006
Vedi nel dettaglio l'esperienza di Antoine Yver

Formazione di Antoine Yver

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

69

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Antoine Yver
40% di sconto: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA